Study of combined opioid and sedative misuse treatment approach
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study looks at how to help people who have misused opioid pain medicines and sedative “sleep/anxiety” drugs (or used alcohol heavily) over the past 10 years. You may be eligible only if you are not actively seeking treatment and you do not have major severe mental health problems or recent overdose/suicide risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had at least 10 years of history taking opioids and sedative drugs (for any reason), even if not at the same time
- Or, if not, you must have used alcohol on at least 3 separate days in the past month
- You are currently in overall good health and not seeking treatment for substance use
- You should not have severe mental health conditions like psychosis, bipolar disorder, or severe depression
- You must not have had a past-month opioid or benzodiazepine (anxiety/sleep medicine) prescription
- You must not have had a drug overdose or suicide attempt/serious thoughts in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who are recently admitted to treatment and are using opioids, benzodiazepines, or both. It aims to help with support during a time when treatment may not yet feel stable.
This trial studies a treatment approach for sleep-disordered breathing (breathing problems during sleep) in Veterans who take prescription opioids. It may help doctors learn safer ways to manage sleep breathing issues that can be made worse by opioid use.
This study explores how opioids and sedative-like drugs interact in the body. It aims to understand their combined effects, which could help improve safety for people who use these drugs.
This Phase 1 study tests how adding psilocybin to a standard opioid treatment (buprenorphine-naloxone) affects recovery and symptoms in people with moderate-to-severe opioid use disorder. It may help researchers understand whether this combination is safe and beneficial alongside medication for opioid withdrawal and cravings.
This study tests a sleep improvement program to help people with chronic widespread pain reduce or stop their opioid pain medication. If you want to cut back on opioids and have trouble sleeping, this treatment might be a good fit.
This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.
Hear when a new Opioid Abuse trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.